SAGE PRO

Home / Research / International Gemological Institute Limited

SAGE PRO · ORIGINAL EQUITY RESEARCH

International Gemological Institute Limited — Q2 FY27 Results Analysis

Investment decision

Published · Quarter Q2 FY27 · IGIL

COMPANY-SPECIFIC GRAPHICAL SUMMARY

What the reported figures reveal

CHART 1

Consolidated operating revenue

Q2 FY26₹3,037.37 million
Q2 FY27₹3,980.24 million
CHART 2

Profit attributable to owners

Q2 FY26₹1,297.93 million
Q2 FY27₹1,858.44 million
CHART 3

H1 cash bridge

Operating cash flow₹4,156.7 million
After cash capex₹3,677.88 million
After capex and lease cash₹3,483.03 million
CHART 4

Owner earnings and operating cash flow

H1 owner PAT₹3,515.8 million
H1 operating cash flow₹4,156.7 million
ORIGINAL RESEARCH INSIGHTS

Investment findings and watch points

RESEARCH INSIGHT

Investment decision

Certification growth is translating into owner earnings. The durability of fees and cash returns depends on product mix, volumes and the acquisition contribution.

Watch: Track the operating and financial tests below.

RESEARCH INSIGHT

Reported operating and financial evidence

Certification growth is translating into owner earnings. The durability of fees and cash returns depends on product mix, volumes and the acquisition contribution.

Watch: Review the company’s filing basis and the next reporting period.

RESEARCH INSIGHT

Reported operating and financial evidence

Certification growth is translating into owner earnings. The durability of fees and cash returns depends on product mix, volumes and the acquisition contribution.

Watch: Review the company’s filing basis and the next reporting period.

RESEARCH INSIGHT

Certification reports

Report volume expanded while average fees declined

Watch: Monitor sequential volume against realized fees

FULL PUBLISHED RESEARCH

Earnings and management commentary analysis

Certification growth is translating into owner earnings. The durability of fees and cash returns depends on product mix, volumes and the acquisition contribution.

1. Investment committee decision and variant thesis

Key takeaways

  • Variant: IGIL can monetize structural certification-volume growth through a trusted grading network with relatively low incremental cash capex.
  • Countercase: acquisition AGL and geographic mix, not organic pricing, partly explain rising average fee and consolidated margin.
  • Q2 FY27 certification revenue INR3,875m rose 31.76% on 26.09% more reports; ARP rose 4.33%, but CFO Eashwar Iyer attributed roughly half of that ARP increase to AGL (IGI-P p5; IGI-T p12).

A decisive disconfirming observation would be persistent falling realized fees or deteriorating cash conversion despite higher report counts. Without independently certified market/peer valuation, this is a research question, not a buy rating or price target.

2. Sector economics, certification mix and skeptical competition

Key takeaways

  • IGIL earns per certification report, not per diamond carat or jewellery retail sale.
  • Mix, turnaround time, independent trust and gemologist utilization drive unit economics.
  • Q2 lab-grown loose-stone certification revenue INR2,111m vs INR1,538m and LGD jewellery INR356m vs INR243m, while natural jewellery INR635m vs INR615m (IGI-P p5).

Sequentially Q2 report count grew from 3.56m to 4.35m (+22.19%), but ARP fell INR1,010 to INR891 (-11.78%), yielding only +7.70% certification revenue (IGI-P p13). A higher number of certificates is not evidence of better pricing. GJEPC-derived industry export data available through IBEF is secondary context only; no original sector report has been certified. Indian listed jewellery retailers are demand-channel references, not like-for-like certification valuation peers.

3. Original signed financial and cash-return bridge

Key takeaways

  • Signed consolidated Ind AS Q2 FY27 revenue from operations INR3,980.24m versus INR3,037.37m; owner PAT INR1,858.44m versus INR1,297.93m, NCI zero (IGI-F p4).
  • H1 owner PAT INR3,515.80m and CFO INR4,156.70m imply 118.23% cash conversion.
  • Cash PPE/CWIP INR409.76m plus acquired intangible INR69.06m leave mechanical CFO-minus-capex INR3,677.88m; deducting lease principal INR147.33m and lease interest INR47.52m leaves INR3,483.03m before dividends/deposits (IGI-F p6).

Working capital benefited from INR466.94m receivable release and INR262.75m higher other current liabilities; not guaranteed recurring. The auditor's unmodified review nevertheless relies on management-prepared information for 11 subsidiaries contributing INR131.19m Q2 PAT (~7.06% of group), and says comparative H1 FY26 cash flow was not reviewed (IGI-F p3).

Consolidated EBITDA margin expanded 340bp YoY to 61.4%, but India standalone margin CONTRACTED 330bp to 69.5% (IGI-P p5,p16): opposite movements need a true geographic/elimination bridge. Historical 12-month CY2023/24/25 revenues INR8,980m/10,532m/12,291m; the INR15,976m to March 2026 is FIFTEEN months, not comparable 12M growth (IGI-P p33). Four-to-eight quarterly signed financial and normalized multi-year return bridges remain incomplete.

4. Transcript Q&A, dated promises and accountability

Key takeaways

  • On the original 21 Oct 2026 earnings call, CFO Eashwar Iyer told analyst Harish Advani that earlier 15% revenue and 20% EBITDA growth guidance was revised upward, with H2 expected broadly similar to H1 growth; he declined a precise new numeric forecast (IGI-T p9,p12).
  • This is NOT_DUE for FY27 ending 31 March 2027, not a delivered commitment.
  • Iyer separately attributed approximately two percentage points of ARP increase to AGL and two to underlying business/mix (IGI-T p12).

Management ranked growth investment first, M&A second and dividends third (IGI-T p9). Test future deployment against actual owner cash and incremental returns; do not count planned expansion as realized profits.

5. Market-implied expectations and valuation blockers

Key takeaways

  • Production canonical price history reports 2 Nov 2026 close INR398.25 tagged NSE_BHAVCOPY_FALLBACK; the actual original NSE bhavcopy was NOT independently downloaded, so price is reference-only.
  • Signed capital INR864.32m at INR2 face value implies 432.16m basic shares (IGI-F p4), giving a mechanical INDICATIVE equity capitalization INR172,107.72m (INR17,210.77cr).
  • Twice H1 PAT gives an UNSAFE annualized INR7,031.60m and indicative P/E 24.48x, not certified trailing or normalized earnings.

Diluted EPS is lower than basic; diluted shares, restricted cash, lease-adjusted enterprise value, a genuine same-date Indian listed certification peer and computed consistent bull/base/bear remain UNVERIFIED. No arbitrary peer multiple, target price or scenario probability is supplied to fill the gap.

6. Risks, thesis breakers and next-period monitoring

Key takeaways

  • Monitor certified reports, consolidated and standalone ARP, LGD versus natural mix, AGL consolidation effects, country contribution and cash conversion after working capital and leases.
  • Q2 ARP INR891 and H1 certification revenue growth approximately 27% are sourced baselines, not management-guaranteed thresholds.
  • Analyst monitoring levels are average revenue per report below ₹891 and H2 revenue growth below 27%.

Both are analytical thresholds. A breach requires mix and seasonality attribution, not an automatic sell signal. Other hard risks: margin compression in standalone India masked by consolidated growth; 11 management-prepared subsidiary figures; 15-month historical comparability; valuation without certified share count and peer economics.

7. Action plan — test certification economics against cash and mix, not growth alone

Key takeaways

  • The actionable variant: The strongest claim for IGIL is not simply that certification revenue rose; it is that a trusted laboratory network might monetize a larger number of certificates while needing less incremental capital than a retailer or manufacturer.
  • This hypothesis must be tested with both *report count* and *average revenue per report*.
  • The issuer's Q2 FY27 presentation shows certification report volume rising sequentially from approximately 3.56 million to 4.35 million, or about 22%.

Average revenue per report concurrently fell from ₹1,010 to ₹891, roughly 12%. Thus sequential certification revenue increased by only about 7.7%. This combination supports strong underlying customer activity but cautions against equating certificates processed with pricing power.

Mix sensitivity: Q2 lab-grown loose-stone certification revenue rose from ₹1,538 million to ₹2,111 million year on year, and lab-grown jewellery revenue from ₹243 million to ₹356 million. Natural jewellery certification revenue increased far more modestly, from ₹615 million to ₹635 million.

A disproportionate shift toward faster-growing categories can change the average report price and the geographical expense structure. The reported consolidated EBITDA margin of 61.4% and India standalone EBITDA margin of 69.5% are different perimeters, and their opposite year-on-year directions do not reconcile automatically.

Each quarter should separate organic IGIL performance from the acquisition contribution and the India-versus-international margin bridge.

Cash quality: H1 FY27 attributable PAT of ₹3,515.80 million compared with operating cash flow of ₹4,156.70 million represents approximately 118% cash conversion on the reported H1 measures. But working capital included a ₹466.94 million receivable release and higher current liabilities.

The mechanical after-capex-and-lease cash bridge of ₹3,483.03 million in the report is *not* a sustainable or audited free-cash-flow forecast. Use actual lease principal, cash interest, maintenance versus growth capex, acquisition costs and seasonality before projecting this figure.

It would be improper to annualize the H1 cash benefit without comparing a full cash cycle.

Three conditional investor outcomes: In a constructive case, higher report counts are accompanied by stable fee realization after adjusting for mix, and acquisition synergies improve cash conversion without impairing laboratory independence. In a neutral case, report volume grows but average fee continues to normalize, yielding respectable but slower revenue growth and a stable margin range.

In an adverse case, price competition or an unfavorable lab-grown mix depresses realized fees while acquired assets or working capital use more cash than expected. These are qualitative scenarios rather than unsupported numerical forecasts or price targets.

Next-quarter monitoring: Compare (1) report volume versus the 4.35 million Q2 reference; (2) average realized fee versus ₹891, with category and country mix; (3) India standalone versus consolidated margin on the same accounting perimeter; (4) operating cash flow after receivables, taxes and leases; (5) AGL organic/inorganic contribution; and (6) progress toward management guidance as it was actually worded on 21 October. A conclusion of stronger business quality should require durable *unit economics*, not only more certificates. Original signed results, presentation and management transcript citations appear below; all thresholds in this section are monitoring references rather than management promises.

Sources and limitations

The report uses the issuer’s Q2 investor presentation, earnings call and reported financial evidence. Valuation depends on normalized earnings, a dated market reference and reconciliation of debt and the diluted share base.

- - -

Additional company evidence

CHART 5

Certification reports

Q1 FY273.56 million reports
Q2 FY274.35 million reports
CHART 6

Average revenue per certification report

Q1 FY27₹1,010 per report
Q2 FY27₹891 per report
CHART 7

Lab-grown loose-stone certification revenue

Q2 FY26₹1,538 million
Q2 FY27₹2,111 million
CHART 8

Lab-grown jewellery certification revenue

Q2 FY26₹243 million
Q2 FY27₹356 million
SOURCE REFERENCES

Original disclosures and investor presentations

Original references are in the published manuscript below.

Related research and comparisons

Other published Q2 FY27 reports

This is dated research, not a live market quote. Scenarios and historical performance are not guarantees.